October 2015 - Page 7 of 9

Slater & Gordon and Shine Corporate are now in value territory after heavy price falls

Aitken Asset Management has ventured into the local market with a health stock highly leveraged to the growing market of cashed-up Chinese consumers.

Medical stocks Cochlear and Resmed were upgraded this week as Veda got two downgrades following an improved takeover offer.

Today we answer readers’ queries about what to do with their Origin rights and how to calculate capital gains tax on Westfield shares.

Fund managers make money for a living, and we can learn a lot from the way they handle market ups and down.

Confused much? Don’t worry, everybody is but you can still make money!

"I share market commentary on TV, radio, and on
Switzer Daily, but for Subscribers I tell them
EXACTLY how I’m investing my money, and I hold nothing back!"